PRE Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 birž. 2024 @ 20:19):
Our systems believe the stock currently is overvalued by -1.64% compare to its pairs and should correct downwards.

Stats
Šios dienos apimtis	75 731
Vidutinė apimtis	101 204
Rinkos kapitalizacija	74.89M
EPS	$-1.570 ( Q4 \| 2024-05-01 )
Kita pelno data	( $0 ) 2024-09-20
Last Dividend	$0.700 ( 2016-02-17 )
Next Dividend	$0 ( N/A )
P/E	-1.430 (Sector) 42.63 (Industry) 39.71
ATR14	$0.0580 (0.96%)

AWH -4.00%

BIAF 0.52%

BIAFW 6.00%

INBS -2.22%

LMDXW 0.00%

PRE -0.49%

PRENW -28.86%

Insider Trading

Date	Person	Action	Amount	type
2016-03-18	Montupet Jean Paul L	Sell	1 750	Restricted Share Units
2016-03-18	Montupet Jean Paul L	Sell	4 459	Non-qualified Stock Option (Right to Buy)
2016-03-18	Montupet Jean Paul L	Sell	9 804	Non-qualified Stock Option (Right to Buy)
2016-03-18	Montupet Jean Paul L	Sell	8 742	Non-qualified Stock Option (Right to Buy)
2016-03-18	Montupet Jean Paul L	Sell	7 268	Non-qualified Stock Option (Right to Buy)

INSIDER POWER
0.00
Last 100 transactions
Buy: 44 374 \| Sell: 871 642

Koreliacija (AI algo v.1.1b): Overvalued: -1.64% $6.13 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: -0.06 (neutral)

Trumpas: -0.67 (moderate negative)

Signal:(42.656) Neutral

Prenetics Global Limited Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Prenetics Global Limited Koreliacija - Valiuta/Žaliavos

-0.17
( neutral )

0.28
( neutral )

0.00
( neutral )

-0.28
( neutral )

0.00
( neutral )

-0.37
( neutral )

Prenetics Global Limited Finansinės ataskaitos

Annual	2023
Pajamos:	$21.74M
Bruto pelnas:	$8.83M (40.61 %)
EPS:	$-5.58

FY	2023
Pajamos:	$21.74M
Bruto pelnas:	$8.83M (40.61 %)
EPS:	$-5.58

FY	2022
Pajamos:	$275.76M
Bruto pelnas:	$131.55M (47.71 %)
EPS:	$-37.57

FY	2021
Pajamos:	$275.85M
Bruto pelnas:	$106.13M (38.47 %)
EPS:	$-1.568

Financial Reports:

No articles found.

Prenetics Global Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Prenetics Global Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 1.691 - low (50.00%) | Divividend Growth Potential Score: 1.723 - No dividend growth expected in the near future

Information

First Dividend	$0.470	2009-05-20
Last Dividend	$0.700	2016-02-17
Next Dividend	$0	N/A
Payout Date	2016-03-01
Next Payout Date	N/A
# dividends	28	--
Total Paid Out	$17.03	--
Avg. Dividend % Per Year	0.00%	--
Score	2.29	--
Div. Sustainability Score	1.691
Div.Growth Potential Score	1.723
Div. Directional Score	1.707	--

Next Divdend (Est)
(2024-09-20)

$0 Estimate 0.00 %

Dividend Stability

0.10 Very Bad

Dividend Score

2.29

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2009	$1.410	2.01%
2010	$2.05	2.78%
2011	$2.35	2.92%
2012	$2.48	3.84%
2013	$2.56	3.14%
2014	$2.68	2.64%
2015	$2.80	2.49%
2016	$0.700	0.50%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
17 Feb 2016	$0.700	08 Feb 2016	30 Nov -0001	01 Mar 2016
04 Nov 2015	$0.700	27 Oct 2015	30 Nov -0001	01 Dec 2015
05 Aug 2015	$0.700	27 Jul 2015	30 Nov -0001	01 Sep 2015
06 May 2015	$0.700	27 Apr 2015	30 Nov -0001	01 Jun 2015
11 Feb 2015	$0.700	02 Feb 2015	30 Nov -0001	27 Feb 2015
18 Nov 2014	$0.670	27 Oct 2014	30 Nov -0001	01 Dec 2014
14 Aug 2014	$0.670	28 Jul 2014	30 Nov -0001	29 Aug 2014
15 May 2014	$0.670	28 Apr 2014	30 Nov -0001	30 May 2014
13 Feb 2014	$0.670	29 Jan 2014	30 Nov -0001	28 Feb 2014
14 Nov 2013	$0.640	28 Oct 2013	30 Nov -0001	29 Nov 2013
15 Aug 2013	$0.640	29 Jul 2013	30 Nov -0001	30 Aug 2013
16 May 2013	$0.640	29 Apr 2013	30 Nov -0001	31 May 2013
14 Feb 2013	$0.640	04 Feb 2013	30 Nov -0001	01 Mar 2013
15 Nov 2012	$0.620	31 Oct 2012	30 Nov -0001	30 Nov 2012
16 Aug 2012	$0.620	30 Jul 2012	30 Nov -0001	31 Aug 2012
17 May 2012	$0.620	01 May 2012	30 Nov -0001	01 Jun 2012
15 Feb 2012	$0.620	06 Feb 2012	30 Nov -0001	01 Mar 2012
16 Nov 2011	$0.600	02 Nov 2011	30 Nov -0001	01 Dec 2011
17 Aug 2011	$0.600	02 Aug 2011	30 Nov -0001	01 Sep 2011
18 May 2011	$0.600	29 Apr 2011	30 Nov -0001	01 Jun 2011

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-2.81	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.259	1.200	-8.62	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.298	1.500	-4.42	-6.63	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.10	0.800	4.48	3.58	[1 - 3]
quickRatioTTM	1.875	0.800	3.68	2.94	[0.8 - 2.5]
cashRatioTTM	1.465	1.500	2.97	4.46	[0.2 - 2]
debtRatioTTM	0.00718	-1.500	9.88	-10.00	[0 - 0.6]
interestCoverageTTM	-605.95	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	1.489	2.00	9.50	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.489	2.00	9.26	10.00	[0 - 20]
debtEquityRatioTTM	0.00877	-1.500	9.96	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.456	1.000	5.74	5.74	[0.2 - 0.8]
operatingProfitMarginTTM	-2.14	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	10.40	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.0920	0.800	-2.72	-2.18	[0.5 - 2]
Total Score				1.691

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.181	1.000	-0.220	0	[1 - 100]
returnOnEquityTTM	-0.298	2.50	-2.84	-6.63	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.489	2.00	9.50	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.489	2.00	9.50	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0438	1.500	-3.63	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.812	1.000	10.00	0	[0.1 - 0.5]
Total Score				1.723

Prenetics Global Limited Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Prenetics Global Limited

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company\'s products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.